Suppr超能文献

非酒精性脂肪性肝病中勃起功能障碍的病因

Causes of erectile dysfunction in non-alcoholic fatty liver disease.

作者信息

Tarik Kani Haluk, Emre Sener Tarik, Emre Aykut Umut, Ozer Demirtas Coskun, Keklikkiran Caglayan, Ergenc Ilkay, Fatih Demirci Abdullah, Kamil Cam Haydar, Celikel Cigdem, Akbal Cem, Duman Deniz

机构信息

Department of Gastroenterology, Marmara University School of Medicine, Istanbul, Turkey.

Department of Urology, Marmara University School of Medicine, Istanbul, Turkey.

出版信息

Hepatol Forum. 2021 May 24;2(2):60-63. doi: 10.14744/hf.2021.2021.0012. eCollection 2021 May.

Abstract

BACKGROUND AND AIM

Erectile dysfunction (ED) is an important and commonly seen disorder in patients with non-alcoholic fatty liver disease (NAFLD). The objective of this study was to assess the rate of ED and its causes in a group of NAFLD patients.

MATERIALS AND METHODS

The International Index of Erectile Function questionnaire (IIEF-5) was used to evaluate the presence, causes, and severity of ED. Participants with an IIEF-5 score of <22 who agreed to undergo a urological evaluation were referred to a urologist for further assessment.

RESULTS

A total of 136 NAFLD patients were enrolled in the study. According to the IIEF-5, 68 (50.0%) patients had ED. Multivariate analysis indicated that older age, obesity, and hypertension were associated with ED. Seventeen patients had multiple etiological factors for ED. Psychogenic ED was identified in 19 patients (39.6%), vasculogenic ED in 35 patients (72.9%), drug-related ED in 3 patients (6.3%), and neurogenic ED in 6 patients (12.5%).

CONCLUSION

ED is frequently seen in NAFLD patients, which may, at least in part, be due to common risk factors. Vasculogenic dysfunction is the most common single source of ED in NAFLD patients. Nonetheless, all potential etiologies should be carefully investigated, with special attention given to psychogenic factors, since they may be more frequent and relevant than expected.

摘要

背景与目的

勃起功能障碍(ED)是非酒精性脂肪性肝病(NAFLD)患者中一种重要且常见的病症。本研究的目的是评估一组NAFLD患者中ED的发生率及其病因。

材料与方法

采用国际勃起功能指数问卷(IIEF-5)评估ED的存在、病因及严重程度。IIEF-5评分<22且同意接受泌尿外科评估的参与者被转介给泌尿外科医生进行进一步评估。

结果

共有136例NAFLD患者纳入本研究。根据IIEF-5,68例(50.0%)患者患有ED。多因素分析表明,年龄较大、肥胖和高血压与ED相关。17例患者存在多种ED病因。19例患者(39.6%)被确定为心理性ED,35例患者(72.9%)为血管性ED,3例患者(6.3%)为药物相关性ED,6例患者(12.5%)为神经性ED。

结论

ED在NAFLD患者中常见,这可能至少部分归因于共同的危险因素。血管功能障碍是NAFLD患者中ED最常见的单一病因。尽管如此,所有潜在病因都应仔细调查,尤其要关注心理因素,因为它们可能比预期更常见且更相关。

相似文献

1
Causes of erectile dysfunction in non-alcoholic fatty liver disease.
Hepatol Forum. 2021 May 24;2(2):60-63. doi: 10.14744/hf.2021.2021.0012. eCollection 2021 May.
2
Nonalcoholic Fatty Liver Disease is Associated with Erectile Dysfunction: A Prospective Pilot Study.
J Sex Med. 2016 Mar;13(3):383-8. doi: 10.1016/j.jsxm.2015.12.030. Epub 2016 Feb 4.
3
Predicting risk of erectile dysfunction in patients with nonalcoholic fatty liver disease.
Andrologia. 2021 Aug;53(7):e14091. doi: 10.1111/and.14091. Epub 2021 May 5.
6
The correlation between erectile dysfunction and metabolic syndrome in an Indian population: A cross-sectional observational study.
Arab J Urol. 2019 Apr 24;17(3):221-227. doi: 10.1080/2090598X.2019.1600990. eCollection 2019.
8
Association of erectile dysfunction with depression in patients with chronic viral hepatitis.
World J Gastroenterol. 2015 May 14;21(18):5641-6. doi: 10.3748/wjg.v21.i18.5641.
9
Can the International Index of Erectile Function distinguish between organic and psychogenic erectile function?
BJU Int. 2008 Aug;102(3):354-6. doi: 10.1111/j.1464-410X.2008.07610.x. Epub 2008 Mar 11.

引用本文的文献

3
Chronic liver diseases and erectile dysfunction.
Front Public Health. 2023 Jan 6;10:1092353. doi: 10.3389/fpubh.2022.1092353. eCollection 2022.

本文引用的文献

1
The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk.
Curr Diab Rep. 2021 Mar 19;21(5):15. doi: 10.1007/s11892-021-01383-7.
2
Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD.
Diabetes Metab. 2020 Sep;46(4):288-295. doi: 10.1016/j.diabet.2019.11.003. Epub 2019 Nov 28.
3
Hepatic fibrosis - and not steatosis - is the main determinant of arterial stiffness in non-alcoholic fatty liver disease.
Atherosclerosis. 2019 Nov;290:222-223. doi: 10.1016/j.atherosclerosis.2019.07.020. Epub 2019 Jul 24.
4
Type 2 diabetes mellitus: A risk factor for progression of liver fibrosis in middle-aged patients with non-alcoholic fatty liver disease.
J Gastroenterol Hepatol. 2019 Nov;34(11):2011-2018. doi: 10.1111/jgh.14734. Epub 2019 Jun 7.
5
Nonalcoholic Fatty Liver Disease, Male Sexual Dysfunction, and Infertility: Common Links, Common Problems.
Sex Med Rev. 2020 Apr;8(2):274-285. doi: 10.1016/j.sxmr.2019.01.002. Epub 2019 Mar 19.
6
Obesity and Weight Gain Are Associated With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Clin Gastroenterol Hepatol. 2019 Feb;17(3):543-550.e2. doi: 10.1016/j.cgh.2018.07.006. Epub 2018 Sep 11.
7
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.
9
Erectile dysfunction in patients with nonalcoholic fatty liver disease.
Arab J Gastroenterol. 2017 Mar;18(1):21-24. doi: 10.1016/j.ajg.2017.02.002. Epub 2017 Mar 16.
10
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.
J Hepatol. 2016 Jun;64(6):1388-402. doi: 10.1016/j.jhep.2015.11.004. Epub 2016 Apr 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验